Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 24 of 101 for:    Behaviors and Mental Disorders[CONDITION-BROWSE-BRANCH] | Recruiting, Not yet recruiting, Available Studies | ( Map: Texas, United States ) | NIH, U.S. Fed

Leveraging Transdermal Alcohol Monitoring to Reduce Drinking Among DWI Defendants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03638596
Recruitment Status : Recruiting
First Posted : August 20, 2018
Last Update Posted : June 27, 2019
Sponsor:
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Information provided by (Responsible Party):
The University of Texas Health Science Center at San Antonio

Brief Summary:
The current study will evaluate the efficacy of contingency management (i.e., reinforcement for avoiding heavy drinking) among adults arrested for drunk driving and who are at risk for ongoing heavy drinking.

Condition or disease Intervention/treatment Phase
Drunk Driving Behavioral: Contingency Management Behavioral: Control Not Applicable

Detailed Description:
Individuals who have a drunk driving arrest and are at risk for ongoing heavy drinking will be recruited to test the efficacy of contingency management for reducing alcohol use and identifying mechanisms of change. We will recruit those arrested for drunk driving offenses, ≥ 21 years of age, who at risk for ongoing heavy alcohol use and randomize them to one of two groups: control or a contingency management. Participants experience 8 weekly assessments of current alcohol use and other variables associated with changes in alcohol use. Post-intervention, participants will return to the laboratory once per month at 3, 6, 9, and 12 months post-study entry for follow-up procedures to determine the mechanisms of drinking behavior change.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 440 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: random assignment to treatment and control arms
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Leveraging Transdermal Alcohol Monitoring to Reduce Drinking Among DWI Defendants
Actual Study Start Date : May 1, 2017
Estimated Primary Completion Date : April 30, 2022
Estimated Study Completion Date : April 30, 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Impaired Driving

Arm Intervention/treatment
Experimental: Contingency Management
Incentive delivery contingent upon maintaining transdermal alcohol concentration below cut-off
Behavioral: Contingency Management
Incentive provided for changing alcohol drinking patterns based on ankle monitor

Placebo Comparator: Control
Incentive delivery not contingent on transdermal alcohol concentration
Behavioral: Control
Incentive provided is not contingent on alcohol drinking patterns based on ankle monitor




Primary Outcome Measures :
  1. Percent heavy drinking days [ Time Frame: 8-weeks ]
    Percent of days with estimated breath alcohol concentration .08% or higher or self-reported drinks > 5 for men and > 4 for women


Secondary Outcome Measures :
  1. Percent drinking days [ Time Frame: 8-weeks ]
    Percent of days with any positive transdermal alcohol concentration >.02 or any self-reported drinks

  2. Follow-up percent heavy drinking days [ Time Frame: 12-months ]
    Self-reported drinks > 5 for men and > 4 for women

  3. Follow-up percent drinking days [ Time Frame: 12-months ]
    Any self-reported drinks



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • arrested for drunk driving offense

Exclusion Criteria:

  • significant alcohol withdrawal symptoms
  • medical condition that would contraindicate participation (e.g., pregnancy, scheduled surgery)
  • inability to comprehend the informed consent process or study instructions
  • presence of a DSM-5 psychiatric disorder with symptoms of psychosis and/or delirium
  • incarceration

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03638596


Contacts
Layout table for location contacts
Contact: Donald Dougherty, PhD 210-567-2728 doughertyd@uthscsa.edu
Contact: Tara Karns-Wright, PhD 210-567-2720 wrightt3@uthscsa.edu

Locations
Layout table for location information
United States, Texas
University of Texas Health Science Center San Antonio Recruiting
San Antonio, Texas, United States, 78229
Contact: Donald Dougherty, PhD    210-567-2728    doughertyd@uthscsa.edu   
Contact: Tara Karns-Wright, PhD    210-567-2720    wrightt3@uthscsa.edu   
Sponsors and Collaborators
The University of Texas Health Science Center at San Antonio
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Investigators
Layout table for investigator information
Principal Investigator: Donald M Dougherty, PhD The University of Texas Health Science Center San Antonio

Layout table for additonal information
Responsible Party: The University of Texas Health Science Center at San Antonio
ClinicalTrials.gov Identifier: NCT03638596     History of Changes
Other Study ID Numbers: HSC20160425H
5R01AA014988 ( U.S. NIH Grant/Contract )
First Posted: August 20, 2018    Key Record Dates
Last Update Posted: June 27, 2019
Last Verified: June 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by The University of Texas Health Science Center at San Antonio:
Alcohol Impaired Driving
Driving While Intoxicated
Driving Under the Influence
Driving While Impaired

Additional relevant MeSH terms:
Layout table for MeSH terms
Ethanol
Anti-Infective Agents, Local
Anti-Infective Agents
Central Nervous System Depressants
Physiological Effects of Drugs